Estrogen therapy and cardiovascular risk in women.

K. M. Bass, T. L. Bush

Research output: Contribution to journalReview articlepeer-review


Estrogen therapy in women has traditionally been used for the relief of menopausal symptoms and protection from osteoporosis. Recently, there has been a growing body of evidence suggesting that estrogen therapy protects against cardiovascular disease in women. An epidemiologic review of the literature demonstrates an approximately 50% reduction in cardiovascular risk in women using estrogen. A brief review of indications, complications, and routes of estrogen administration is presented. Current areas of controversy include the effects of parenteral estrogen administration and progestin administration on the cardioprotective aspects of estrogen therapy and the risk of breast cancer in estrogen users. Further study in these areas is needed.

Original languageEnglish (US)
Pages (from-to)33-39
Number of pages7
JournalThe Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
Issue number5
StatePublished - May 1991

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Estrogen therapy and cardiovascular risk in women.'. Together they form a unique fingerprint.

Cite this